Justin Sherin, Antony Beena
Department of Microbiology, AJ Institute of Medical Sciences and Research Centre, Mangalore, Karnataka, India.
Department of Microbiology, Father Muller Medical College, Mangalore, Karnataka, India.
Indian J Med Microbiol. 2019 Apr-Jun;37(2):186-191. doi: 10.4103/ijmm.IJMM_17_357.
Prevalence of Clostridium difficile, an anaerobic, Gram-positive, spore-forming bacillus, is very much underestimated in India. The present study was intended to assess the burden of toxigenic C. difficile in hospitalised patients with clinically significant diarrhoea and analysis of their clinical picture.
This cross-sectional study was conducted in a tertiary care teaching hospital, South India, from January 2012 to December 2014. Stool samples were collected consecutively from 563 inpatients from various wards. The prevalence of toxigenic C. difficile was determined by toxigenic culture and a two-step algorithm. The clinical spectrum of these patients was also analysed. Associated pathogens were identified using standard procedures. Statistical analysis was done by frequency, percentage, Chi-square test and z-test.
Out of the 563 stool samples analysed, the prevalence of toxigenic C. difficile was 12.79% and that of non-toxigenic C. difficile was 10.83%. The prevalence of toxigenic C. difficile among oncology patients was highly significant (HS). Antibiotic treatment, prolonged hospital stay and underlying diseases/conditions were the risk factors which were HS, and fever was the significant clinical feature among the patients. Escherichia coli was the predominant associated pathogen isolated (18.47%).
The presence of toxigenic C. difficile in our locality is a matter of concern. Constant supervision, appropriate treatment and preventive measures are crucial in controlling C. difficile infection.
艰难梭菌是一种厌氧、革兰氏阳性、产芽孢杆菌,在印度其流行率被严重低估。本研究旨在评估住院的有临床显著腹泻的患者中产毒艰难梭菌的负担,并分析其临床症状。
本横断面研究于2012年1月至2014年12月在印度南部的一家三级护理教学医院进行。连续从各个病房的563名住院患者中收集粪便样本。通过产毒培养和两步算法确定产毒艰难梭菌的流行率。还对这些患者的临床谱进行了分析。使用标准程序鉴定相关病原体。通过频率、百分比、卡方检验和z检验进行统计分析。
在分析的563份粪便样本中,产毒艰难梭菌的流行率为12.79%,非产毒艰难梭菌的流行率为10.83%。肿瘤患者中产毒艰难梭菌的流行率非常显著(HS)。抗生素治疗、住院时间延长和基础疾病/状况是具有高度显著性(HS)的危险因素,发热是患者中的显著临床特征。大肠埃希菌是分离出的主要相关病原体(18.47%)。
我们当地存在产毒艰难梭菌令人担忧。持续监督、适当治疗和预防措施对于控制艰难梭菌感染至关重要。